Zhen M. Zhuang - Publications

Corrigendum to "Integrated multiplex PCR and metatranscriptomics reveal upper-lower airway microbial landscapes in pediatric respiratory infections" [Virol. Sin. 41 (2026) 58-69].

Journal: Virologica Sinica

Published: June 11, 2026

Analysis of the association between occupational benzene series exposure and obstructive ventilatory disorder

Journal: Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases

Published: May 25, 2026

Integrated multiplex PCR and metatranscriptomics reveal upper-lower airway microbial landscapes in pediatric respiratory infections.

Journal: Virologica Sinica

Published: August 26, 2025

Nanoparticle vaccine based on the pre-fusion F glycoprotein of respiratory syncytial virus elicits robust protective immune responses.

Journal: Journal of virology

Published: August 26, 2025

Unveiling the epitope repertoires and protective roles of MERS-CoV-specific T cells in mice.

Journal: Cell reports

Published: July 21, 2025

In vivo determination of protective antibody thresholds for SARS-CoV-2 variants using mouse models.

Journal: Emerging microbes & infections

Published: January 24, 2025

Interferon-stimulated gene GALNT2 restricts respiratory virus infections.

Journal: Nature microbiology

Published: December 03, 2024

A nucleoside-modified mRNA vaccine prevents enterovirus A71 infection in mouse model.

Journal: Frontiers in immunology

Published: November 27, 2024

Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunctional resident memory in patient lungs.

Journal: Nature immunology

Published: June 04, 2024

Harnessing T-Cells for Enhanced Vaccine Development against Viral Infections.

Journal: Vaccines

Published: March 27, 2024

Characterization of humoral immune responses against SARS-CoV-2 accessory proteins in infected patients and mouse model.

Journal: Virologica Sinica

Published: November 05, 2023

P21-activated kinase 1 (PAK1)-mediated cytoskeleton rearrangement promotes SARS-CoV-2 entry and ACE2 autophagic degradation.

Journal: Signal transduction and targeted therapy

Published: February 01, 2023